![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SSUH2 |
Gene summary for SSUH2 |
![]() |
Gene information | Species | Human | Gene symbol | SSUH2 | Gene ID | 51066 |
Gene name | ssu-2 homolog | |
Gene Alias | C3orf32 | |
Cytomap | 3p25.3 | |
Gene Type | protein-coding | GO ID | GO:0007275 | UniProtAcc | Q9Y2M2 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
51066 | SSUH2 | HCC1_Meng | Human | Liver | HCC | 3.48e-08 | 2.15e-02 | 0.0246 |
51066 | SSUH2 | Pt14.a | Human | Liver | HCC | 6.10e-03 | 1.76e-01 | 0.0169 |
51066 | SSUH2 | S016 | Human | Liver | HCC | 3.39e-02 | 1.24e-01 | 0.2243 |
51066 | SSUH2 | S027 | Human | Liver | HCC | 2.39e-12 | 4.93e-01 | 0.2446 |
51066 | SSUH2 | S028 | Human | Liver | HCC | 2.23e-23 | 7.01e-01 | 0.2503 |
51066 | SSUH2 | S029 | Human | Liver | HCC | 3.57e-22 | 6.64e-01 | 0.2581 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Liver | ![]() | HCC: Hepatocellular carcinoma |
NAFLD: Non-alcoholic fatty liver disease |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | CRC | ![]() |
Stomach | GC | ![]() |
Stomach | CAG with IM | ![]() |
Stomach | CSG | ![]() |
Stomach | CAG | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SSUH2 | SNV | Missense_Mutation | novel | c.877N>C | p.Tyr293His | p.Y293H | Q9Y2M2 | protein_coding | deleterious(0) | probably_damaging(0.971) | TCGA-AO-A128-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | SD |
SSUH2 | SNV | Missense_Mutation | novel | c.245C>T | p.Ala82Val | p.A82V | Q9Y2M2 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-D8-A3Z6-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | cyclophosphane | SD |
SSUH2 | SNV | Missense_Mutation | c.479A>C | p.Gln160Pro | p.Q160P | Q9Y2M2 | protein_coding | deleterious(0.04) | possibly_damaging(0.744) | TCGA-E9-A1NC-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | CR | |
SSUH2 | insertion | Frame_Shift_Ins | novel | c.1067_1068insTGTGGCTGTTT | p.His357ValfsTer91 | p.H357Vfs*91 | Q9Y2M2 | protein_coding | TCGA-A2-A04V-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cytoxan | PD | ||
SSUH2 | insertion | In_Frame_Ins | novel | c.1066_1067insCGTCCTGTTTGC | p.Asp356delinsAlaSerCysLeuHis | p.D356delinsASCLH | Q9Y2M2 | protein_coding | TCGA-A2-A04V-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cytoxan | PD | ||
SSUH2 | SNV | Missense_Mutation | novel | c.418N>T | p.Pro140Ser | p.P140S | Q9Y2M2 | protein_coding | deleterious(0.02) | probably_damaging(0.964) | TCGA-EA-A3HU-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
SSUH2 | SNV | Missense_Mutation | rs776971510 | c.322N>T | p.Arg108Trp | p.R108W | Q9Y2M2 | protein_coding | deleterious(0.02) | benign(0.019) | TCGA-Q1-A5R2-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | PR |
SSUH2 | SNV | Missense_Mutation | c.215N>A | p.Pro72His | p.P72H | Q9Y2M2 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-A6-2686-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
SSUH2 | SNV | Missense_Mutation | c.713N>T | p.Ala238Val | p.A238V | Q9Y2M2 | protein_coding | tolerated(0.13) | benign(0.306) | TCGA-A6-3809-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
SSUH2 | SNV | Missense_Mutation | rs748228423 | c.218N>T | p.Ala73Val | p.A73V | Q9Y2M2 | protein_coding | tolerated(0.98) | benign(0) | TCGA-CK-6746-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |